PURPOSE: The most common long-term complication of joint arthroplasty is aseptic loosening. The proinflammatory cytokines secreted by macrophages are involved in aseptic loosening. Recently, a novel proinflammatory cytokine IL-17C was reported to participate in inflammatory diseases by synergising with proinflammatory cytokines. However, the relationship between IL-17C and the aseptic loosening is unclear. METHODS: The tissues around aseptic loosened implants were collected during revision surgery and handled by formalin fixation and embedded in paraffin. The presence of IL-17C in the tissues around the aseptic loosened implants was investigated in 12 aseptic loosening patients using immunofluorescence. RESULTS: The presence of IL-17C protein in the tissues around aseptic loosened implants was detected by immunofluorescence. There are no statistical differences between optical density of IL-17C in aseptic loosening samples and in rheumatoid arthritis samples (positive control). CONCLUSIONS: These results suggest the presence of IL-17C in aseptic loosening. Interleukin-17C was related to the inflammation of aseptic loosening, possibly by contributing to the inflammation and osteolysis in the tissues surrounding aseptic loosened implants.
PURPOSE: The most common long-term complication of joint arthroplasty is aseptic loosening. The proinflammatory cytokines secreted by macrophages are involved in aseptic loosening. Recently, a novel proinflammatory cytokine IL-17C was reported to participate in inflammatory diseases by synergising with proinflammatory cytokines. However, the relationship between IL-17C and the aseptic loosening is unclear. METHODS: The tissues around aseptic loosened implants were collected during revision surgery and handled by formalin fixation and embedded in paraffin. The presence of IL-17C in the tissues around the aseptic loosened implants was investigated in 12 aseptic loosening patients using immunofluorescence. RESULTS: The presence of IL-17C protein in the tissues around aseptic loosened implants was detected by immunofluorescence. There are no statistical differences between optical density of IL-17C in aseptic loosening samples and in rheumatoid arthritis samples (positive control). CONCLUSIONS: These results suggest the presence of IL-17C in aseptic loosening. Interleukin-17C was related to the inflammation of aseptic loosening, possibly by contributing to the inflammation and osteolysis in the tissues surrounding aseptic loosened implants.
Authors: Jennifer L Nalepka; Michael J Lee; Matthew J Kraay; Randall E Marcus; Victor M Goldberg; Xin Chen; Edward M Greenfield Journal: Clin Orthop Relat Res Date: 2006-10 Impact factor: 4.176
Authors: Qun Wu; Richard J Martin; John G Rino; Rachel Breed; Raul M Torres; Hong Wei Chu Journal: Microbes Infect Date: 2006-12-15 Impact factor: 2.700
Authors: Y Nakashima; D H Sun; M C Trindade; W J Maloney; S B Goodman; D J Schurman; R L Smith Journal: J Bone Joint Surg Am Date: 1999-05 Impact factor: 5.284
Authors: P Edward Purdue; Panagiotis Koulouvaris; Hollis G Potter; Bryan J Nestor; Thomas P Sculco Journal: Clin Orthop Relat Res Date: 2007-01 Impact factor: 4.176
Authors: M M Tunney; S Patrick; M D Curran; G Ramage; D Hanna; J R Nixon; S P Gorman; R I Davis; N Anderson Journal: J Clin Microbiol Date: 1999-10 Impact factor: 5.948
Authors: Michael T Clarke; Christopher P Roberts; Paul T H Lee; Jim Gray; Graham S Keene; Neil Rushton Journal: Clin Orthop Relat Res Date: 2004-10 Impact factor: 4.176